Visual feedback from the SpiroGym app for breathing training in Parkinson's
Official title: The Effect of Visual Feedback From the SpiroGym Mobile Application on Expiratory Muscle Strength Training Performance in Patients With Parkinson's Disease
Run by General University Hospital, Prague · NCT06942533 · Data updated 2026-11-12
This study will test whether real-time visual feedback from the SpiroGym app helps people with Parkinson's improve strength and performance during expiratory breathing exercises.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 80 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | General University Hospital, Prague Academic / other |
| Locations | 2 sites (Prague and 1 other locations) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | May 1, 2026 |
| Study ends | July 1, 2026 |
| Registry record updated | December 1, 2025 |
| Trial ID | NCT06942533 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People with a diagnosis of Parkinson's disease who are on a stable dose of dopaminergic medication and who do not have major cognitive, psychiatric, or other neurological disorders are ideal candidates.
✕Probably not a fit
Patients with significant cognitive impairment, other neurological disorders, unstable dopaminergic treatment, or a history of head or neck cancer or surgery are unlikely to qualify or benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized crossover study has participants with Parkinson's disease complete two expiratory muscle strength training (EMST) sessions at 75% of their maximum expiratory pressure, with a two-week interval between sessions. One session uses the SpiroGym mobile app to provide real-time visual feedback and the other session is performed without the app, with the order randomized. Outcomes include muscle activation measured by surface electromyography (sEMG), noise intensity recorded by SpiroGym as a proxy for expiratory performance, and participant-reported perceived difficulty and motivation. The design tests whether immediate visual feedback changes physiological effort and subjective experience during EMST.
Why it matters
Potential benefit: If successful, adding SpiroGym's visual feedback could make breathing exercises more effective and motivating, potentially improving cough strength and airway protection for people with Parkinson's.
How similar studies have gone: Prior pilot EMST work, including with SpiroGym, has shown rapid improvements in cough-related measures, but the specific added benefit of real-time visual feedback remains unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of Parkinsons disease * Stable dopaminergic medication (stable dose for at least 1 month) Exclusion Criteria: * Other neurological disorders * Significant cognitive impairment * Major psychiatric disorder * History of head or neck cancer or previous surgical interventions in the neck region. * Illness during the study period
Where it's running
-
General University Hospital
Prague, Czechia Recruiting -
Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague
Prague, Czechia Recruiting
Study contacts
- Study coordinator: Martin Srp, Ph.D.
- Email: martin.srp@vfn.cz
- Phone: +420224965513
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Outpatient Cardiac Telerehabilitation for Ischemic Heart Disease
This study tests whether an outpatient cardiac telerehabilitation program can be as safe and effective as conventional rehab for people with ischemic heart disease.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Tele-diabetes remote monitoring for kids with type 1 diabetes
This study tests a tele-diabetes remote system that uses WhatsApp alerts to help children and teens manage their type 1 diabetes at home.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.